Dr. Moore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
125 Lattimore Rd Ste 258
Rochester, NY 14620Phone+1 585-442-8020Fax+1 585-442-8039- Is this information wrong?
Summary
- I am Board Certified in Gynecologic Oncology and Obstetrics and Gynecology. I am a Fellow of the ACOG and a Fellow American College of Surgeons
Education & Training
- Women and Infants Hospital of Rhode Island/Brown UniversityFellowship, Gynecologic Oncology, 1999 - 2002
- Eastern Virginia Medical SchoolResidency, Obstetrics and Gynecology, 1993 - 1997
- University of AlbertaClass of 1993
Certifications & Licensure
- NY State Medical License 2015 - 2024
- MA State Medical License 2001 - 2016
- RI State Medical License 1999 - 2016
- CT State Medical License 2002 - 2015
- NC State Medical License 1997 - 2003
- VA State Medical License 1996 - 2002
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Ovarian Cancer Risk Estimation in Patients With Pelvic Mass Start of enrollment: 2009 Oct 01
- Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass. Start of enrollment: 2016 Jun 30
- EP0057 in Combination With Olaparib in Advanced Ovarian Cancer Start of enrollment: 2020 Dec 14
Roles: Contact
Publications & Presentations
PubMed
- A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomes.Eva Culakova, Lisa Blanchard, Nellie Wixom, Joseph J Guido, Michelle C Janelsins, Karen M Mustian, Luke J Peppone, Erin K Campbell, Thomas M Campbell, James Fetten, Al...> ;Breast Cancer Research and Treatment. 2024 Mar 30
- Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment ...Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, Whitney Graybill, Domenica Lorusso, Colleen C McCormick, Gilles Freyer, Floor Backes, Florian Heitz, Andrés R...> ;Future Oncology. 2024 Mar 19
- 2 citationsA whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomes.Thomas M Campbell, Erin K Campbell, Eva Culakova, Lisa M Blanchard, Nellie Wixom, Joseph J Guido, James Fetten, Alissa Huston, Michelle Shayne, Michelle C Janelsins, K...> ;Breast Cancer Research and Treatment. 2024 Mar 6
- Join now to see all
Press Mentions
- Targeted Treatment for Ovarian Cancer DiscoveredFebruary 19th, 2014
- FDA Clears Biomarker Test for Ovarian CancerSeptember 6th, 2011
Professional Memberships
- Member
Hospital Affiliations
- Strong Memorial Hospital of the University of RochesterRochester, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: